Great Lakes Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,873
| Closed | -$204K | – | 873 |
|
|
2023
Q1 | $204K | Sell |
1,873
-567
| -23% | -$61.9K | ﹤0.01% | 771 |
|
|
2022
Q4 | $278K | Buy |
+2,440
| New | +$278K | 0.02% | 573 |
|
|
2022
Q3 | – | Sell |
-2,915
| Closed | -$233K | – | 730 |
|
|
2022
Q2 | $233K | Sell |
2,915
-233
| -7% | -$18.6K | ﹤0.01% | 612 |
|
|
2022
Q1 | $331K | Sell |
3,148
-744
| -19% | -$78.2K | 0.01% | 580 |
|
|
2021
Q4 | $419K | Sell |
3,892
-175
| -4% | -$18.8K | 0.01% | 541 |
|
|
2021
Q3 | $445K | Sell |
4,067
-640
| -14% | -$70K | 0.01% | 535 |
|
|
2021
Q2 | $441K | Sell |
4,707
-47
| -1% | -$4.4K | 0.01% | 535 |
|
|
2021
Q1 | $438K | Buy |
4,754
+235
| +5% | +$21.7K | 0.01% | 524 |
|
|
2020
Q4 | $331K | Sell |
4,519
-101
| -2% | -$7.4K | 0.01% | 534 |
|
|
2020
Q3 | $359K | Buy |
4,620
+667
| +17% | +$51.8K | 0.01% | 478 |
|
|
2020
Q2 | $220K | Buy |
+3,953
| New | +$220K | 0.01% | 520 |
|
|
2017
Q4 | – | Sell |
-556,229
| Closed | -$7.05M | – | 631 |
|
|
2017
Q3 | $7.05M | Buy |
+556,229
| New | +$7.05M | 0.17% | 110 |
|